Gene · 7399
Papers2,630
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,630
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| High prevalence of exon-13 variants in USH2A-related retinal dystrophies in Taiwanese population. | Orphanet J Rare Dis | 2024 | 38879497 | PubTator, text mining | PubMed |
| Clinical and genetic characterization of patients with eye diseases included in the Spanish Rare Diseases Patient Registry. | Orphanet J Rare Dis | 2024 | 38872169 | PubTator, text mining | PubMed |
| Spectrum of genetic variants in 306 patients with non-syndromic hearing loss from Croatia. | Croat Med J | 2024 | 38868966 | PubTator, text mining | PubMed |
| Whole-Exome Sequencing in Turkish Patients with Inherited Retinal Dystrophies Reveals Novel Variants in Ten Genes. | Mol Syndromol | 2024 | 38841332 | PubTator, text mining | PubMed |
| Self-Reported Functional Vision in USH2A-Associated Retinal Degeneration as Measured by the Michigan Retinal Degeneration Questionnaire. | Invest Ophthalmol Vis Sci | 2024 | 38833260 | PubTator, text mining | PubMed |
| Whole genome sequencing identifies elusive variants in genetically unsolved Italian inherited retinal disease patients. | HGG Adv | 2024 | 38816995 | PubTator, text mining | PubMed |
| Next-generation sequencing to genetically diagnose a diverse range of inherited eye disorders in 15 consanguineous families from Pakistan. | Exp Eye Res | 2024 | 38815792 | PubTator, text mining | PubMed |
| Identification of novel and known genetic variants associated with hereditary hearing loss in iranian families using whole exome sequencing. | Mol Biol Rep | 2024 | 38767670 | PubTator, text mining | PubMed |
| HCMV US2 co-opts TRC8 to degrade the endoplasmic reticulum-resident protein LMAN2L. | J Gen Virol | 2024 | 38687323 | PubTator, text mining | PubMed |
| [Analysis of the results for genetic disease screening among 1 000 newborns from Huzhou]. | Zhonghua Yi Xue Yi Chuan Xue Za Zhi | 2024 | 38684299 | PubTator, text mining | PubMed |
| Syndromic Retinitis Pigmentosa: A 15-Patient Study. | Genes (Basel) | 2024 | 38674450 | PubTator, text mining | PubMed |
| Metabolomics facilitates differential diagnosis in common inherited retinal degenerations by exploring their profiles of serum metabolites. | Nat Commun | 2024 | 38670966 | PubTator, text mining | PubMed |
| Beyond the phenotype: Exploring inherited retinal diseases with targeted next-generation sequencing in a Turkish cohort. | Clin Genet | 2024 | 38576124 | PubTator, text mining | PubMed |
| Next-generation sequencing based newborn screening and comparative analysis with MS/MS. | BMC Pediatr | 2024 | 38561707 | PubTator, text mining | PubMed |
| Color fundus imaging: The backbone of our journey in genotype-phenotype correlation. | Indian J Ophthalmol | 2024 | 38546475 | PubTator, text mining | PubMed |
| Navigating the Usher Syndrome Genetic Landscape: An Evaluation of the Associations between Specific Genes and Quality Categories of Cochlear Implant Outcomes. | Audiol Res | 2024 | 38525684 | PubTator, text mining | PubMed |
| Next-generation sequencing reveals genetic heterogeneity and resistance mechanisms in patients with EGFR-mutated non-small cell lung cancer treated with afatinib. | ERJ Open Res | 2024 | 38500795 | PubTator, text mining | PubMed |
| [Multimodal imaging of USH2A rod-cone dystrophy: Case report]. | J Fr Ophtalmol | 2024 | 38480036 | PubTator, text mining | PubMed |
| Retinal Ciliopathies and Potential Gene Therapies: A Focus on Human iPSC-Derived Organoid Models. | Int J Mol Sci | 2024 | 38474133 | PubTator, text mining | PubMed |
| A pipeline for identifying guide RNA sequences that promote RNA editing of nonsense mutations that cause inherited retinal diseases. | Mol Ther Nucleic Acids | 2024 | 38375504 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7399/papers?page=10